Home NDC 0003-0898 ELIQUIS SPRINKLE
Product NDC 0003-0898
11-digit product format 000030898
Labeler code 0003
Product ID 0003-0898_f96cb5ea-74e9-4751-883d-d18ef0d83640
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name apixaban
Dosage form CAPSULE
Route ORAL
Labeler E.R. Squibb & Sons, L.L.C.
Application NDA220073
Marketing category NDA
Marketing start 2025-09-15
Substance APIXABAN
Active strength .15 mg/1
Pharmacologic classes Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N220073-001 ELIQUIS SPRINKLE APIXABAN 0.15MG FOR SUSPENSION / ORAL RLD, RS 2025-04-17
Orange Book patents# Current patent rows page 1 of 1 · 4 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N220073-001 6967208 2026-11-21 U-4180 Drug substance, Drug product 2025-05-16 N220073-001 6967208*PED 2027-05-21 Pediatric extension N220073-001 11896586 2040-11-22 U-4180 Drug product 2025-05-16 N220073-001 11896586*PED 2041-05-22 Pediatric extension
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N220073-001 NP 2028-04-17 N220073-001 PED 2028-10-17
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N220073-001 ELIQUIS SPRINKLE 0.15MG FOR SUSPENSION / ORAL RLD, RS 2025-04-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N220073-001 ELIQUIS SPRINKLE 0.15MG FOR SUSPENSION / ORAL RLD, RS 2025-04-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N220073-001 ELIQUIS SPRINKLE 0.15MG FOR SUSPENSION / ORAL RLD, RS 2025-04-17 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220073-001 ELIQUIS SPRINKLE 0.15MG FOR SUSPENSION / ORAL RLD, RS 2025-04-17 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N220073-001 6967208 2026-11-21 U-4180 Drug substance, Drug product 2025-05-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N220073-001 6967208*PED 2027-05-21 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N220073-001 11896586 2040-11-22 U-4180 Drug product 2025-05-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N220073-001 11896586*PED 2041-05-22 Pediatric extension 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N220073-001 6967208 2026-11-21 U-4180 Drug substance, Drug product 2025-05-16 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N220073-001 6967208*PED 2027-05-21 Pediatric extension 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N220073-001 11896586 2040-11-22 U-4180 Drug product 2025-05-16 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N220073-001 11896586*PED 2041-05-22 Pediatric extension 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N220073-001 6967208 2026-11-21 U-4180 Drug substance, Drug product 2025-05-16 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N220073-001 6967208*PED 2027-05-21 Pediatric extension 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N220073-001 11896586 2040-11-22 U-4180 Drug product 2025-05-16 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N220073-001 11896586*PED 2041-05-22 Pediatric extension 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220073-001 6967208 2026-11-21 U-4180 Drug substance, Drug product 2025-05-16 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220073-001 6967208*PED 2027-05-21 Pediatric extension a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220073-001 11896586 2040-11-22 U-4180 Drug product 2025-05-16 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220073-001 11896586*PED 2041-05-22 Pediatric extension a50c72e98297…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-02-19 14:30 UTC 2026-02 N220073-001 NP 2028-04-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N220073-001 PED 2028-10-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N220073-001 NP 2028-04-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N220073-001 PED 2028-10-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N220073-001 NP 2028-04-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N220073-001 PED 2028-10-17 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220073-001 NP 2028-04-17 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220073-001 PED 2028-10-17 a50c72e98297…
Additional Listing Data#
Finished product Yes
Brand name base ELIQUIS SPRINKLE
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength APIXABAN .15 mg/1
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 0003-0898-28 00003089828 28 CAPSULE in 1 BOTTLE (0003-0898-28) 28 capsule 2025-09-15 No No Current